News

Sep 2022   The Cryoviva Group has cord blood laboratories in Thailand, Singapore, India, and Vietnam, and is active in banking MSC for regenerative medicine therapies. The Cryoviva Group believes that the future of the biobanking industry is to partner in providing cell therapies.

Sep 2022   ExCellThera is a biotechnology company based in Montréal that is dedicated to making cord blood transplants available to a more diverse group of patients by expanding small cord blood units so that they are big enough for therapy.

Aug 2022   Currently, 110 clinical trials with cord blood are recruiting at 281 locations. Cumulatively, 276 clinical trials performing advanced cell therapies with cord blood have been registered through the end of 2021.

Aug 2022   The United Arab Emirates has a well established and officially sanctioned infrastructure for medical tourism. Approvals for biotherapies are more readily obtained than in many western nations, leading to a booming business in regenerative medicine. At the same time, regulations around the practice of regenerative medicine follow high quality standards and are strictly enforced. New this year, the UAE is requiring that cord blood banks which operate in their country must construct a laboratory and storage facility in their country.

Jul 2022   The ReCord study is backtracking childhood leukemia to the genetic mutations present in the child's cord blood at birth. Hopefully this knowledge can be used in the future to predict which children are predisposed to childhood cancer and prevent the diagnosis.

Jul 2022   The World Stem Cell Summit, in partnership with the Regenerative Medicine Foundation, has presented their 2022 Advocacy Award to Dr. Frances Verter & the Parent’s Guide to Cord Blood Foundation. 

Jun 2022   This May, Future Health celebrated its 20th anniversary. Starting from a small biotech lab, they have grown to encompass six subsidiaries in Europe and a global reach of 94 countries. In 2022, Future Health is set to open a new biobanking storage facility in Nottingham to meet increasing demand. The new facility will include green technologies as part of the Future Health commitment to our environment and sustainability.

Jun 2022   Kinetic Stem Cell Counting is the first technology that can directly count stem cells. It is based on the unique property of stem cells, that they are capable of asymmetric self-renewal. This makes it possible to run a computer simulation of a growing culture that determines the number of stem cells present. Once validated for a specified combination of cell type and culture conditions, Kinetic Stem Cell Counting provides a stem cell count after only 3 DAYS of cell culture. 

May 2022   In pursuit of cell therapy for their children, more parents are traveling to Mexico. Regenerative medicine treatments are legal in Mexico, but not all providers are following the existing laws. When evaluating "stem cell" clinics in Mexico, parents should look carefully at things like their licensing, where they get their cells, will you be treated by a medical doctor, is the procedure performed in a medical facility?

Apr 2022   One of the variations between different MSC therapeutics is hemocompatibility: the risk that a high dose MSC infusion will trigger a blood clot. There is increasing risk of thromboembolism with MSC infusions as the MSC source goes from bone marrow, to perinatal tissue, to adipose tissue. Research shows that the risk can be quantified by testing the MSCs for their expression of procoagulant tissue factor (TF/CD142). It is also important to raise awareness of this risk factor so that both patients and their caregivers will recognize the symptoms of thromboembolism and seek appropriate medical care.